1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsGrants Program - Innovative Programs is sponsored by Rolfe Pancreatic Cancer Foundation. This program funds organizations that have identified specific needs of pancreatic cancer patients, survivors, and their families.
Get alerted about grants like this
Get emailed when new opportunities from “Rolfe Pancreatic Cancer Foundation” or related funders appear. Free, weekly, unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Advancing Early Detection and Treatment: Rolfe Foundation Grant Impact 2024 - Rolfe Pancreatic Cancer Foundation Advancing Early Detection and Treatment: Rolfe Foundation Grant Impact 2024 Rolfe Pancreatic Cancer Foundation continues to drive meaningful progress in early detection and treatment of Pancreatic Cancer through grants that fund pioneering research and essential support services.
These dollars not only bring hope but also move us closer to breakthrough discoveries. Research-Focused Grants : $277,000 Revealing the Origin of Pancreatic Cancer Metastases Principal Investigator: Dr. Oren Parnas, Hebrew University of Jerusalem Dr. Parnas’s groundbreaking research explores how and when Pancreatic Cancer cells spread to other organs.
By leveraging cutting-edge tools like single-cell RNA and CRISPR screening, his team aims to uncover early detection markers and identify weaknesses in the metastatic process, a critical step in improving patient outcomes.
Pancreatic Tissue and Tumor Analysis Projects Johns Hopkins University (3 projects led by emerging leaders in pathology) Fibroblast Influence in Tumor Invasion : Investigating how cells in the tumor environment promote cancer spread using advanced 3-D tissue models.
3-D Study of Liver Metastases : Dr. Ashley Kiemen’s work reconstructs liver metastases in unprecedented detail, revealing patterns of cancer spread and response to treatment. Fibroblast Characteristics in ATM-Deficient Cancers : Dr. Nicholas Roberts explores unique tumor environments in genetically predisposed cases, paving the way for personalized therapies.
Biomarker Discovery for Early Detection Principal Investigator: Dr. Alex Muir, University of Chicago Medicine This innovative study focuses on identifying lymphatic and interstitial fluid biomarkers, offering a less invasive and more precise pathway to detecting Pancreatic Cancer at earlier stages. Digital Tools for Risk Assessment Principal Investigators: Drs.
Sonia Kupfer, Christine Drogan, Ophir Gilad, and Emma Keel, University of Chicago Medicine This project addresses disparities in genetic testing and early cancer detection, particularly among underserved populations, by implementing a patient-directed digital cancer risk tool. Lustgarten’s comprehensive research program focuses on improving patient outcomes.
Its programs include early detection and interception, therapeutic development, and personalized medicine, which brings cutting-edge science from the lab to the clinic. Support for Partner Organizations : $25,000 Cancer Wellness Center: Offering vital counseling, support groups, wellness activities, and outreach to patients and families affected by Pancreatic Cancer.
Wellness House: Providing free, life-changing programs to improve the emotional and physical well-being of cancer patients and their loved ones. Thanks to Rolfe Foundation’s strategic funding, these efforts are making a measurable impact in the fight against Pancreatic Cancer. While challenges remain, the progress achieved so far serves as a beacon of hope for patients and families worldwide.
Together, we’re not just envisioning breakthroughs—we’re making them possible. The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Organizations that have identified specific needs of pancreatic cancer patients, survivors, and their families. Confirm the full requirements in the official notice before applying.
Grants Program - Innovative Programs is funded by Rolfe Pancreatic Cancer Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.
Smart Health and Biomedical Research in the Era of Artificial Intelligence and Advanced Data Science (SCH) is sponsored by National Science Foundation (NSF) & National Institutes of Health (NIH). This interagency program supports high-risk, high-reward advances in AI and data science for biomedical and public health research. Projects must cross disciplinary boundaries.